Cullen Capital Management LLC Takes $2.08 Million Position in DuPont de Nemours, Inc. $DD

Cullen Capital Management LLC bought a new position in shares of DuPont de Nemours, Inc. (NYSE:DDFree Report) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 15,341 shares of the basic materials company’s stock, valued at approximately $2,081,000.

A number of other hedge funds and other institutional investors have also modified their holdings of DD. PNC Financial Services Group Inc. grew its holdings in DuPont de Nemours by 21.8% during the 4th quarter. PNC Financial Services Group Inc. now owns 1,119,613 shares of the basic materials company’s stock worth $45,008,000 after acquiring an additional 200,550 shares during the period. Swiss Life Asset Management Ltd grew its stake in DuPont de Nemours by 1,519.9% in the fourth quarter. Swiss Life Asset Management Ltd now owns 1,022,145 shares of the basic materials company’s stock valued at $41,090,000 after acquiring an additional 959,047 shares during the period. Independent Advisor Alliance increased its stake in DuPont de Nemours by 517.8% during the 4th quarter. Independent Advisor Alliance now owns 42,052 shares of the basic materials company’s stock worth $1,691,000 after purchasing an additional 35,245 shares in the last quarter. Danske Bank A S increased its position in shares of DuPont de Nemours by 16.1% during the fourth quarter. Danske Bank A S now owns 374,460 shares of the basic materials company’s stock worth $15,053,000 after acquiring an additional 51,845 shares in the last quarter. Finally, Sequoia Financial Advisors LLC raised its holdings in shares of DuPont de Nemours by 71.8% during the fourth quarter. Sequoia Financial Advisors LLC now owns 804,520 shares of the basic materials company’s stock worth $32,342,000 after acquiring an additional 336,148 shares during the period. Institutional investors and hedge funds own 73.96% of the company’s stock.

DuPont de Nemours Price Performance

NYSE:DD opened at $136.71 on Tuesday. DuPont de Nemours, Inc. has a 12-month low of $92.49 and a 12-month high of $157.98. The firm has a market capitalization of $18.46 billion, a price-to-earnings ratio of 303.86, a P/E/G ratio of 1.26 and a beta of 1.06. The stock’s 50 day moving average price is $139.54 and its two-hundred day moving average price is $141.34. The company has a quick ratio of 1.82, a current ratio of 2.43 and a debt-to-equity ratio of 0.23.

DuPont de Nemours (NYSE:DDGet Free Report) last issued its earnings results on Tuesday, August 4th. The basic materials company reported $1.88 EPS for the quarter, topping the consensus estimate of $1.76 by $0.12. DuPont de Nemours had a return on equity of 6.92% and a net margin of 0.67%.The company had revenue of $1.82 billion during the quarter, compared to the consensus estimate of $1.81 billion. During the same period in the previous year, the company posted $1.12 EPS. The firm’s revenue for the quarter was up 4.0% compared to the same quarter last year. DuPont de Nemours has set its Q3 2026 guidance at 1.800-1.900 EPS. On average, analysts anticipate that DuPont de Nemours, Inc. will post 7.27 earnings per share for the current year.

DuPont de Nemours Cuts Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Monday, August 31st will be given a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date of this dividend is Monday, August 31st. DuPont de Nemours’s payout ratio is 533.33%.

Analyst Ratings Changes

A number of equities analysts have issued reports on DD shares. BMO Capital Markets increased their target price on DuPont de Nemours from $75.30 to $180.00 and gave the stock an “outperform” rating in a report on Tuesday, May 5th. UBS Group upped their price objective on DuPont de Nemours from $175.00 to $178.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. Morgan Stanley increased their price objective on DuPont de Nemours from $132.00 to $156.00 and gave the stock an “equal weight” rating in a report on Tuesday, April 28th. The Goldman Sachs Group lifted their target price on DuPont de Nemours from $53.00 to $159.00 and gave the company a “neutral” rating in a research report on Thursday, June 25th. Finally, JPMorgan Chase & Co. boosted their target price on DuPont de Nemours from $171.00 to $172.00 and gave the company an “overweight” rating in a research note on Monday, August 10th. Twelve equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $166.60.

Read Our Latest Report on DuPont de Nemours

DuPont de Nemours Profile

(Free Report)

DuPont de Nemours (NYSE: DD) is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.

DuPont’s operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.

Featured Articles

Want to see what other hedge funds are holding DD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DuPont de Nemours, Inc. (NYSE:DDFree Report).

Institutional Ownership by Quarter for DuPont de Nemours (NYSE:DD)

Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.